Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis.
暂无分享,去创建一个
G. Guyatt | K. Khush | H. Ross | A. Alba | F. Foroutan | L. Truby | Y. Moayedi | T. Buchan | J. D. Posada
[1] R. Kormos,et al. Outcomes of the First 1300 Adult Heart Transplants in the United States After the Allocation Policy Change. , 2020, Circulation.
[2] Pavel S. Roshanov,et al. Use of GRADE for assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks. , 2020, Journal of clinical epidemiology.
[3] S. Restaino,et al. Discontinuing amiodarone treatment prior to heart transplantation lowers incidence of severe primary graft dysfunction , 2020, Clinical transplantation.
[4] C. Hayward,et al. Long-term Outcome in Severe Left Ventricular Primary Graft Dysfunction Post Cardiac Transplantation Supported by Early Use of Extracorporeal Membrane Oxygenation , 2019, Transplantation.
[5] M. Pasque,et al. Comparison of outcomes in lung and heart transplant recipients from the same multiorgan donor , 2019, Clinical transplantation.
[6] G. Couper,et al. A case series: the outcomes, support duration, and graft function recovery after VA-ECMO use in primary graft dysfunction after heart transplantation , 2019, Journal of Artificial Organs.
[7] J. Mehaffey,et al. Primary graft dysfunction after heart transplantation: Outcomes and resource utilization , 2019, Journal of cardiac surgery.
[8] B. Meiser,et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[9] P. Leprince,et al. Favorable Outcome of an Exclusively Posttransplant Prophylactic Strategy After Heart Transplantation in Recipients With High Immunological Risk. , 2019, Transplantation.
[10] D. Freimark,et al. Does donor‐recipient age difference matter in outcome of heart transplantation? , 2019, Clinical transplantation.
[11] G. Gonzalez-Stawinski,et al. Extracorporeal membrane oxygenation as a salvage therapy for patients with severe primary graft dysfunction after heart transplant , 2019, Clinical transplantation.
[12] G. Guyatt,et al. Validation of the International Society for Heart and Lung Transplantation primary graft dysfunction instrument in heart transplantation. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[13] N. Al-Attar,et al. ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study , 2019, Transplantation.
[14] Y. Naka,et al. Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[15] M. Antunes,et al. Primary graft failure after cardiac transplantation: prevalence, prognosis and risk factors. , 2018, Interactive cardiovascular and thoracic surgery.
[16] X. Armoiry,et al. Extracorporeal life support for primary graft dysfunction after heart transplantation. , 2018, Interactive cardiovascular and thoracic surgery.
[17] D. Freimark,et al. Donor‐recipient ethnic mismatching impacts short‐ and long‐term results of heart transplantation , 2018, Clinical transplantation.
[18] J. Felius,et al. Reoperative sternotomy is associated with primary graft dysfunction following heart transplantation. , 2018, Interactive cardiovascular and thoracic surgery.
[19] M. Beňa,et al. Short-term mechanical circulatory support for severe primary graft dysfunction following orthotopic heart transplant. , 2018, Interactive cardiovascular and thoracic surgery.
[20] J. Felius,et al. Donor predicted heart mass as predictor of primary graft dysfunction. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[21] M. Swaminathan,et al. Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[22] A. Ardehali,et al. Primary graft dysfunction in heart transplantation , 2018, Current opinion in organ transplantation.
[23] A. Pavie,et al. Predictive value of liver damage for severe early complications and survival after heart transplantation: A retrospective analysis. , 2018, Clinics and research in hepatology and gastroenterology.
[24] L. Potena,et al. Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[25] A. Ducharme,et al. EARLY CIRCULATORY SUPPORT WITH EXTRACORPOREAL MEMBRANE OXYGENATION IMPROVES OUTCOMES AFTER SEVERE GRAFT DYSFUNCTION , 2017 .
[26] B. Levin,et al. Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[27] Y. Sakata,et al. Factors Related to the Severity of Early Postoperative Infection After Heart Transplantation in Patients Surviving Prolonged Mechanical Support Periods: Experience at a Single University. , 2017, Journal of cardiothoracic and vascular anesthesia.
[28] C. Chabanne,et al. Impact of donor comorbidities on heart transplant outcomes in the modern era. , 2017, Interactive cardiovascular and thoracic surgery.
[29] M. Farr,et al. Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[30] T. Kohmoto,et al. To use or not to use? Amiodarone before heart transplantation , 2017, Surgery.
[31] D. Dunkler,et al. Acute Kidney Injury and Outcome After Heart Transplantation: Large Differences in Performance of Scoring Systems , 2016, Transplantation.
[32] E. Roig,et al. Prognostic Value of High-Sensitivity Troponin-T to Identify Patients at Risk of Left Ventricular Graft Dysfunction After Heart Transplantation. , 2016, Transplantation proceedings.
[33] J. Squiers,et al. Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre† , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[34] P. Loyalka,et al. Clinical Factors Implicated in Primary Graft Dysfunction After Heart Transplantation: A Single-center Experience. , 2016, Transplantation proceedings.
[35] J. Pirk,et al. Biomarkers of cellular apoptosis and necrosis in donor myocardium are not predictive of primary graft dysfunction. , 2016, Physiological research.
[36] H. Ishibashi-Ueda,et al. Incidence, etiology, and outcome of primary graft dysfunction in adult heart transplant recipients: a single-center experience in Japan , 2016, Heart and Vessels.
[37] M. Kuchibhatla,et al. Elevated Cardiac Troponin I in Preservation Solution Is Associated With Primary Graft Dysfunction. , 2016, Journal of cardiac failure.
[38] F. Atik,et al. Experience of ECMO in Primary Graft Dysfunction after Orthotopic Heart Transplantation , 2015, Arquivos brasileiros de cardiologia.
[39] G. Guyatt,et al. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients , 2015, BMJ : British Medical Journal.
[40] J. Pirk,et al. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support. , 2015, Interactive cardiovascular and thoracic surgery.
[41] M. Aerts,et al. Metaprop: a Stata command to perform meta-analysis of binomial data , 2014, Archives of Public Health.
[42] M. Pilato,et al. Extracorporeal Membrane Oxygenation for Graft Failure after Heart Transplantation: A Multidisciplinary Approach to Maximize Weaning Rate , 2014, The International journal of artificial organs.
[43] S. Russell,et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[44] C. Bombardier,et al. Assessing Bias in Studies of Prognostic Factors , 2013, Annals of Internal Medicine.
[45] G. Guyatt,et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.
[46] D. Moher,et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, PloS one.
[47] J. Barceló,et al. RADIAL: a novel primary graft failure risk score in heart transplantation. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[48] G. Guyatt,et al. Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interest. , 2019, Journal of clinical epidemiology.